Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy

Publisher: John Wiley & Sons Inc

E-ISSN: 1757-4684|10|2|239-253

ISSN: 1757-4676

Source: EMBO Molecular Medicine, Vol.10, Iss.2, 2018-02, pp. : 239-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract